Objectives
The primary objective of the meta-trial is to demonstrate that inhaled nebulised UFH in hospitalised patients with COVID-19 who do not require immediate invasive mechanical ventilation, significantly reduces the proportion of patients who are intubated to receive invasive mechanical ventilation at day 28, compared to standard care alone.